Hepatitis A risk factors and outcomes in children
Part of Digestive system, Infections clinical trials.
This study looks at children with hepatitis A to understand what increases the risk of severe illness and what happens to them over time. It may help improve how doctors care for kids with this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 1 month and 18 years old.
- A doctor must have confirmed hepatitis A infection with a positive blood test.
- Your parent or guardian must agree to let you participate by signing a consent form.
- You cannot have other hepatitis infections (B, C, or E) or chronic liver disease.
- You cannot have conditions like autoimmune hepatitis, Wilson disease, or other metabolic liver diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how the immune system responds in children with acute hepatitis A (a liver infection). Participation may help doctors better understand the body's natural defenses and improve care for other children.
This trial is for children and teens (0–17 years) who are in the hospital or emergency department with acute hepatitis (sudden liver inflammation). The study aims to learn more about the condition and how to best treat it.
This study looks at long-term survival in people ages 18–65 who are hospitalized with hepatitis B–related acute-on-chronic liver failure. It may help doctors better predict prognosis and improve care for people with this serious condition.
This study looks at why children develop sudden liver failure and what affects their recovery. It aims to help doctors better understand and treat this serious condition.
This study looks at why acute liver failure happens and what factors affect recovery. It may help you and your doctor understand the condition better and guide treatment decisions.
This study checks whether a single dose of the hepatitis A vaccine helps protect people with cirrhosis who have no immunity. It aims to see how well the vaccine works and your body's response.
Hear when a new Hepatitis A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.